focus -WSS

focus

author：fashion 2025-09-14 21:46:26 - browse：1

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Victims of gun violence feel impacts long after bullet wound

leisure time

WSS

Removing probiotics from the NICU could threaten preemies' health

Excited delirium, Elijah McClain, and emergency physicians

Study: New antibiotic targets gonorrhea as well as last existing drug

Removing probiotics from the NICU could threaten preemies' health

The a glaring gap in research on serious mental illness and primary care

The cancer stories no one wants to hear

hotspot

focus

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Diversify hospital leadership teams to protect BIPOC patient health

Novavax promises a turnaround & Lilly roils the obesity market

2 officers injured in shooting in Orlando, police say

Cancer drug shortages should be causing more outrage

White House calls on federal agencies to crack down on AI abuses

Jerome Adams on the need for new antivirals for Covid

Senate panel clears PBM, hopsital reforms

Drug repurposing or repositioning? The language matters

The Sacklers, horror, and ‘The Fall of the House of Usher’

hotspot

UCSF medical school apologizes for unethical prisoner experiments

2 officers injured in shooting in Orlando, police say

More doctors should go into startup world

White House calls on federal agencies to crack down on AI abuses

2 officers injured in shooting in Orlando, police say

Sanofi CEO defends move to abandon profit guidance, boost research

leisure time

Wikipedia

leisure time

focus